|
|
Volumn 33, Issue 4, 2001, Pages 2469-2472
|
|
Outcome of PTLD in renal and liver allograft recipients
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACICLOVIR;
AZATHIOPRINE;
CYCLOSPORIN;
IMMUNOGLOBULIN M ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISOLONE;
TACROLIMUS;
THYMOCYTE ANTIBODY;
ADULT;
AGED;
ARTICLE;
CAUSE OF DEATH;
CLINICAL ARTICLE;
EPSTEIN BARR VIRUS;
FEMALE;
GRAFT REJECTION;
HEMATOLOGY;
HUMAN;
KIDNEY ALLOGRAFT;
LIVER TRANSPLANTATION;
LYMPHOPROLIFERATIVE DISEASE;
MALE;
MORTALITY;
OUTCOMES RESEARCH;
PRIORITY JOURNAL;
PROGNOSIS;
RECIPIENT;
REMISSION;
ADULT;
AGED;
DRUG THERAPY, COMBINATION;
EPSTEIN-BARR VIRUS INFECTIONS;
FEMALE;
HERPESVIRUS 4, HUMAN;
HUMANS;
IMMUNOSUPPRESSION;
IMMUNOSUPPRESSIVE AGENTS;
INCIDENCE;
KIDNEY TRANSPLANTATION;
LIVER TRANSPLANTATION;
LYMPHOMA;
LYMPHOPROLIFERATIVE DISORDERS;
MALE;
MIDDLE AGED;
POSTOPERATIVE COMPLICATIONS;
RETROSPECTIVE STUDIES;
SURVIVAL RATE;
TIME FACTORS;
TRANSPLANTATION, HOMOLOGOUS;
|
|
EID: 0034851585
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(01)02051-6 Document Type: Article |
|
Times cited : (14)
|
|
References (20)
|
